Related references
Note: Only part of the references are listed.Use of risk-based cervical screening programs in resource-limited settings
Rebecca B. Perkins et al.
CANCER EPIDEMIOLOGY (2023)
Cost-Effectiveness Analysis of HPV Extended versus Partial Genotyping for Cervical Cancer Screening in Singapore
Brandon Chua et al.
CANCERS (2023)
Pregnancy Outcomes in Women With a Prior Cervical Intraepithelial Neoplasia Grade 3 Diagnosis A Nationwide Population-Based Cohort Study With Sibling Comparison Design
Wei He et al.
ANNALS OF INTERNAL MEDICINE (2022)
Extended Human Papillomavirus Genotyping to Predict Progression to High-Grade Cervical Precancer: A Prospective Cohort Study in the Southeastern United States
Alexandra Bukowski et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2022)
The IARC Perspective on Cervical Cancer Screening
Veronique Bouvard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
2020 list of human papillomavirus assays suitable for primary cervical cancer screening
Marc Arbyn et al.
CLINICAL MICROBIOLOGY AND INFECTION (2021)
Organized primary human papillomavirus-based cervical screening: A randomized healthcare policy trial
K. Miriam Elfstrom et al.
PLOS MEDICINE (2021)
Cervical cancer case-control audit: Results from routine evaluation of a nationwide cervical screening program
Jiangrong Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Impact of HPV vaccination on cervical screening performance: a population-based cohort study
Jiayao Lei et al.
BRITISH JOURNAL OF CANCER (2020)
Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
Laila Sara Arroyo Muhr et al.
BRITISH JOURNAL OF CANCER (2020)
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programs
Maria Demarco et al.
ECLINICALMEDICINE (2020)
Bayesian analysis of baseline risk of CIN2 and ≥CIN3 by HPV genotype in a European referral cohort
Jesper Bonde et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination?
Farhana Sultana et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
Camilla Lagheden et al.
BRITISH JOURNAL OF CANCER (2018)
Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56-60
Helena Lamin et al.
BMJ OPEN (2017)
Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
Jiangrong Wang et al.
PLOS MEDICINE (2017)
Registry-based assessment of the status of cervical screening in Sweden
K. Miriam Elfstrom et al.
JOURNAL OF MEDICAL SCREENING (2016)
Need for expanded HPV genotyping for cervical screening
Jack Cuzick et al.
PAPILLOMAVIRUS RESEARCH (2016)
Long-term HPV type-specific risks for ASCUS and LSIL: A 14-year follow-up of a randomized primary HPV screening trial
K. Miriam Elfstrom et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Judging the carcinogenicity of rare human papillomavirus types
Jean-Damien Combes et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Long-term HPV type-specific risks of high-grade cervical intraepithelial lesions: A 14-year follow-up of a randomized primary HPV screening trial
Vitaly Smelov et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
Are 20 human papillomavirus types causing cervical cancer?
Marc Arbyn et al.
JOURNAL OF PATHOLOGY (2014)
Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials
Guglielmo Ronco et al.
LANCET (2014)
A cross sectional study of HPV type prevalence according to age and cytology
Elena Argyri et al.
BMC INFECTIOUS DISEASES (2013)
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
Davit Bzhalava et al.
VIROLOGY (2013)
Screening and cervical cancer cure: population based cohort study
Bengt Andrae et al.
BMJ-BRITISH MEDICAL JOURNAL (2012)
Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia Grade 3
Philip E. Castle et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The completeness of the Swedish Cancer Register - a sample survey for year 1998
Lotti Barlow et al.
ACTA ONCOLOGICA (2009)
Prevaccination Distribution of Human Papillomavirus Types in Women Attending at Cervical Cancer Screening in Belgium
Marc Arbyn et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2009)
Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
Peter Sasieni et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Human papillomavirus and papanicolaou tests to screen for cervical cancer
Pontus Naucler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology:: a meta-analysis
Silvia de Sanjose et al.
LANCET INFECTIOUS DISEASES (2007)
Disease impact number and population impact number: population perspectives to measures of risk and benefit
RF Heller et al.
BRITISH MEDICAL JOURNAL (2000)